Federation Des Caisses Desjardins Du Quebec Immunome Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Immunome Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 352 shares of IMNM stock, worth $6,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
352
Previous 352
-0.0%
Holding current value
$6,033
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
170Shares Held
71.6MCall Options Held
325KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.42MShares$144 Million0.06% of portfolio
-
Redmile Group, LLC San Francisco, CA5.02MShares$86.1 Million6.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$83.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.82MShares$82.7 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$69.9 Million3.55% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $208M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...